Odonate Therapeutics, Inc. – NASDAQ:ODT

Odonate Therapeutics stock price today

$1.12

Odonate Therapeutics stock price monthly change

+2.75%
month

Odonate Therapeutics stock price quarterly change

-65.43%
quarter

Odonate Therapeutics stock price yearly change

-95.70%
year

Odonate Therapeutics key metrics

Market Cap
 N/A
Enterprise value
 N/A
P/E
 -0.41
EV/Sales
 N/A
EV/EBITDA
 0.46
Price/Sales
 N/A
Price/Book
 0.59
PEG ratio
 0.03
EPS
 -2.83
Revenue
 N/A
EBITDA
 -101.57M
Income
 -102.06M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Odonate Therapeutics stock price history

Odonate Therapeutics stock forecast

Odonate Therapeutics financial statements

Profit Margin

Odonate Therapeutics, Inc. (NASDAQ:ODT): Profit margin
Dec 2020 0 -32.28M
Mar 2021 0 -33.76M
Jun 2021 0 -22.01M
Sep 2021 0 -13.99M
ODT income statement history

Quarterly Earnings

Odonate Therapeutics, Inc. (NASDAQ:ODT): Earnings per share (EPS)
2021-02-23 -0.78 -0.83
2021-05-14 -0.81 -0.9
ODT earnings history

Debt to Assets

Odonate Therapeutics, Inc. (NASDAQ:ODT): Debt to assets
Dec 2020 167886000 31.74M 18.91%
Mar 2021 142879000 37.57M 26.3%
Jun 2021 118573000 33.94M 28.63%
Sep 2021 105773000 34.40M 32.52%
ODT balance sheet history

Cash Flow

Odonate Therapeutics, Inc. (NASDAQ:ODT): Cash Flow
Dec 2020 -31.50M -16K 524K
Mar 2021 -24.90M -21K 825K
Jun 2021 -23.02M -5K 0
Sep 2021 -15.09M 0 0
ODT cash flow history

Odonate Therapeutics alternative data

Odonate Therapeutics
Employees

Odonate Therapeutics, Inc. (NASDAQ:ODT): Employee count
Aug 2023 137
Sep 2023 137
Oct 2023 137
Nov 2023 137
Dec 2023 137
Jan 2024 137
Feb 2024 137
Mar 2024 137
Apr 2024 137
May 2024 137
Jun 2024 137
Jul 2024 137

Odonate Therapeutics other data

Odonate Therapeutics
Insider Trading

Odonate Therapeutics, Inc. (NASDAQ:ODT): Insider trades (number of shares)
Period Buy Sel
Nov 2021 0 5347131
Dec 2021 185941 5887610
Transaction Date Insider Security Shares Price per share Total value Source
Sale
ECOR1 CAPITAL, LLC 10 percent owner
 Common Stock 5,545,000 $1.61 $8,910,815
Sale
ECOR1 CAPITAL, LLC 10 percent owner
 Common Stock 156,669 $1.82 $284,981
Sale
ECOR1 CAPITAL, LLC 10 percent owner
 Common Stock 185,941 $1.66 $308,662
Purchase
ECOR1 CAPITAL, LLC 10 percent owner
 Common Stock 185,941 $1.66 $308,662
Sale
BOXER CAPITAL, LLC 10 percent owner
 Common Stock 200,000 $1.57 $313,600
Sale
BOXER CAPITAL, LLC 10 percent owner
 Common Stock 200,000 $1.55 $309,600
Sale
BOXER CAPITAL, LLC director, 10 percent owner
 Common Stock 150,000 $1.84 $276,300
Sale
DAVIS AARON I. director, 10 percent owner
 Common Stock 180,000 $1.88 $338,220
Sale
TANG KEVIN C director, 10 perc.. Common Stock 365,289 $1.92 $699,894
Sale
BOXER CAPITAL, LLC director, 10 percent owner
 Common Stock 250,000 $1.95 $487,250
ODT insider trading transactions

Odonate Therapeutics
Patents

Patent
Application
Filling date: 5 Sep 2019 Issue date: 16 Dec 2021
Application
Filling date: 1 Jun 2018 Issue date: 11 Jun 2020
ODT patents

Frequently Asked Questions (FAQ)

  • What's the price of Odonate Therapeutics stock today?

    One share of Odonate Therapeutics stock can currently be purchased for approximately $1.12.

  • When is Odonate Therapeutics's next earnings date?

    Unfortunately, Odonate Therapeutics's (ODT) next earnings date is currently unknown.

  • Does Odonate Therapeutics pay dividends?

    No, Odonate Therapeutics does not pay dividends.

  • What is Odonate Therapeutics's stock symbol?

    Odonate Therapeutics, Inc. is traded on the NASDAQ under the ticker symbol "ODT".

  • What is Odonate Therapeutics's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Odonate Therapeutics?

    Shares of Odonate Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Odonate Therapeutics's key executives?

    Odonate Therapeutics's management team includes the following people:

    • Mr. Michael S. Hearne Chief Financial Officer & Principal Accounting Officer(age: 62, pay: $251,230)
    • Mr. Kevin C. Tang Chairman & Chief Executive Officer(age: 58, pay: $1)

  • How many employees does Odonate Therapeutics have?

    As Jul 2024, Odonate Therapeutics employs 137 workers.

  • When Odonate Therapeutics went public?

    Odonate Therapeutics, Inc. is publicly traded company for more then 7 years since IPO on 7 Dec 2017.

  • What is Odonate Therapeutics's official website?

    The official website for Odonate Therapeutics is odonate.com.

  • Where are Odonate Therapeutics's headquarters?

    Odonate Therapeutics is headquartered at 4747 Executive Dr Ste 510, San Diego, CALIFORNIA.

  • How can i contact Odonate Therapeutics?

    Odonate Therapeutics's mailing address is 4747 Executive Dr Ste 510, San Diego, CALIFORNIA and company can be reached via phone at +1 858 200 3830.

Odonate Therapeutics company profile:

Odonate Therapeutics, Inc.

odonate.com
Exchange:

NASDAQ

Full time employees:

137

Industry:

Biotechnology

Sector:

Healthcare

Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was founded in 2013 and is based in New York, New York.

+1 858 200 3830
4747 Executive Dr Ste 510
San Diego, CALIFORNIA 10016

CIK: 0001717452
:
: